Methylenedioxymethoxyethylamphetamine

Methylenedioxymethoxyethyl­amphetamine

Names
Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine
Identifiers
CAS Number	74698-44-5 Y
3D model (JSmol)	Interactive image
ChemSpider	21106334 N
PubChem CID	44719584
UNII	YPA4B5U3U8
CompTox Dashboard (EPA)	DTXSID10660371
InChI InChI=1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 N Key: LOZJEWOZOKSOKA-UHFFFAOYSA-N N InChI=1/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 Key: LOZJEWOZOKSOKA-UHFFFAOYAB
SMILES CC(Cc1ccc2c(c1)OCO2)NCCOC
Properties
Chemical formula	C13H19NO3
Molar mass	237.295 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

MDMEOET, or 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.